IDEXX Laboratories Inc (IDXX)
417.51
-1.04
(-0.25%)
USD |
NASDAQ |
Nov 22, 10:54
IDEXX Laboratories Shareholders Equity (Quarterly): 1.618B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 1.618B |
June 30, 2024 | 1.580B |
March 31, 2024 | 1.569B |
December 31, 2023 | 1.485B |
September 30, 2023 | 1.297B |
June 30, 2023 | 1.094B |
March 31, 2023 | 841.10M |
December 31, 2022 | 608.74M |
September 30, 2022 | 476.00M |
June 30, 2022 | 457.01M |
March 31, 2022 | 639.80M |
December 31, 2021 | 689.99M |
September 30, 2021 | 754.75M |
June 30, 2021 | 747.46M |
March 31, 2021 | 702.70M |
December 31, 2020 | 632.09M |
September 30, 2020 | 440.58M |
June 30, 2020 | 272.96M |
March 31, 2020 | 107.67M |
December 31, 2019 | 177.47M |
September 30, 2019 | 202.42M |
June 30, 2019 | 171.25M |
March 31, 2019 | 51.56M |
December 31, 2018 | -9.513M |
September 30, 2018 | -1.604M |
Date | Value |
---|---|
June 30, 2018 | -41.13M |
March 31, 2018 | -49.27M |
December 31, 2017 | -54.11M |
September 30, 2017 | -48.62M |
June 30, 2017 | -86.34M |
March 31, 2017 | -74.09M |
December 31, 2016 | -108.35M |
September 30, 2016 | 54.85M |
June 30, 2016 | -8.638M |
March 31, 2016 | -73.92M |
December 31, 2015 | -84.12M |
September 30, 2015 | -38.89M |
June 30, 2015 | 8.468M |
March 31, 2015 | 34.02M |
December 31, 2014 | 117.52M |
September 30, 2014 | 229.39M |
June 30, 2014 | 452.87M |
March 31, 2014 | 512.22M |
December 31, 2013 | 518.19M |
September 30, 2013 | 534.85M |
June 30, 2013 | 549.55M |
March 31, 2013 | 631.25M |
December 31, 2012 | 636.22M |
September 30, 2012 | 617.51M |
June 30, 2012 | 589.93M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
107.67M
Minimum
Mar 2020
1.618B
Maximum
Sep 2024
809.57M
Average
696.34M
Median
Shareholders Equity (Quarterly) Benchmarks
Agilent Technologies Inc | 5.903B |
Bio-Rad Laboratories Inc | 7.488B |
Regeneron Pharmaceuticals Inc | 29.33B |
West Pharmaceutical Services Inc | 2.752B |
NovaBay Pharmaceuticals Inc | 1.072M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 3.351B |
Total Liabilities (Quarterly) | 1.733B |
Debt to Equity Ratio | 0.5401 |
Current Ratio | 1.421 |
Net Debt Paydown Yield | 0.08% |